Cell and Gene Therapy for Personalised Medicine (CGT4PM2027) supports multinational research teams developing and validating novel cell and gene therapies to improve health outcomes through personalised medicine.
Cell and Gene Therapy for Personalised Medicine (CGT4PM2027) supports human health researchers in developing and validating innovative cell and gene therapies to advance personalised medicine.
Career Development Awards from ASGCT support early-career scientists and postdoctoral fellows with transformative gene and cell therapy pilot studies to build independent research careers.
Leveraging functional genomics to reveal novel targets for cancer treatment supports research teams studying tumour heterogeneity to identify and validate more precise targets for cancer treatment.
Clinical Research supports clinicians and researchers conducting non-commercial human and veterinary studies to generate new knowledge that improves clinical practice, diagnostics, and treatment.
Phase 1 including first-in-human clinical trials supports research teams testing biomarker-guided medicines or multi-modal treatments to establish early safety and efficacy for rare cancers.